STAT
AUGUST 17, 2023
billion recorded in 2021. Bancel is in the process of donating a vast majority of his income to charities. That amount of money could buy Costco memberships for more than 66 million people, and it’s equivalent to the entire economic output of Sierra Leone. That CEO haul was down 11% from the $4.5
pharmaphorum
JANUARY 28, 2021
It’s important that the biosimilar market continue to build on the success established last year in 2021. Based on this momentum, we’re making three predictions for 2021: we will see increased competition within individual markets pay off, expansion in the biosimilar channel to include new therapeutic categories, and more regulatory support.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
FEBRUARY 4, 2022
Lilly is a little vague on when it will now file donanemab with the FDA – suggesting on its fourth quarter 2021 results call that it may do so later this year – but reiterated that it has little hope of the drug being used ahead of the readout of TRAILBLAZER-ALZ 2 in mid-2023.
Putting Patients First Blog
OCTOBER 15, 2023
In 2021, the NHC updated its Policy Recommendations for Reducing Health Care Costs. As the primary insurer for millions of Americans and as the programs that drive decisions throughout the health ecosystem, these federal programs can be a critical driver of innovations. The specific comments below are informed by those recommendations.
Putting Patients First Blog
MARCH 4, 2024
Under the new Manufacturer Discount Program, manufacturers will be required to provide discounts on applicable drugs during the initial coverage phase and catastrophic phase of the defined standard Part D drug benefit.
Putting Patients First Blog
JANUARY 10, 2024
Making available more specific information about total costs and coverage will ensure that all consumers have comprehensive information to help them make smart health care decisions. These resources should aim to clarify insurance terms and concepts, aiding consumers in navigating the complexities of selecting a health plan.
pharmaphorum
OCTOBER 1, 2022
In this latest coverage, pharmaphorum speaks with Eugene Borukhovich. Borukhovich is hesitant to compare this year’s conference with the 2021 event. “I If we look at insurers, during the kind of peak of the pandemic, insurers were not paying out, so, there was in theory lots of cash saved up for further investments.
Expert insights. Personalized for you.
246 
Let's personalize your content